section name header

Y-Site Injection Compatibility (1:1 Mixture)

Metronidazole

(Mfr: HOS)(Conc: 5 mg/mLh)

I

Oritavancin diphosphate

(Mfr: TAR)(Conc: 2 mg/mLa)

Remarks:

Fine particles form immediately

Ref:

2928